Relationship between xanthine oxidase gene polymorphisms and anti-tuberculosis drug-induced liver injury in a Chinese population

被引:4
|
作者
Ai, Xin [1 ]
Huang, Hangxing [1 ]
Miao, Zhimin [1 ]
Zhou, Tao [1 ]
Wu, He [1 ]
Lai, Yong [1 ]
机构
[1] Dali Univ, Coll Pharm, Dept Pharmacol, 32 Jia Shi Bo Ave, Dali 671000, Yunnan, Peoples R China
关键词
Anti-tuberculosis drug; Liver injury; Genetic  polymorphism; Xanthine oxidase; Drug metabolizing enzymes; INDUCED HEPATOTOXICITY; N-ACETYLTRANSFERASE-2; GENE; MOLECULAR-CLONING; ADVERSE EVENTS; RISK-FACTORS; PYRAZINAMIDE; ASSOCIATION; METABOLITES; EXPRESSION; HEPATITIS;
D O I
10.1016/j.meegid.2021.104991
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study was designed to investigate the association of the xanthine oxidase (XO) polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury (ATDILI) in Chinese population. A total of 183 tuberculosis patients were enrolled. Patients with ATDILI were classified as cases and those without ATDILI were classified as controls. Genotyping for XO polymorphisms was determined by polymerase chain reaction and direct sequencing. The allele frequencies and genotype distribution was analyzed using the Chi square test to analyze the association between the gene polymorphisms and ATDILI. Binary logistic regression analysis was performed to assess the risk factors of ATDILI. A total of 21 patients were developed liver injury during antituberculosis treatment in this study, with an incidence of 11.48%. In genotype analysis, no significant difference was observed in the alleles and genotypes frequencies of the six SNPs between two groups (P 0.05). In haplotype analysis, carriers with GGGATA (rs1884725- rs2295475 -rs45523133- rs206812- rs206813rs7575607) haplotype had a significantly higher risk of ATDILI compared with other haplotypes (OR = 2.445, 95%CI: 1.058-5.652, P < 0.05). This study suggested that the haplotype GGGATA constructed with rs206812 and rs7575607 mutant alleles might contribute to ATDILI susceptibility in a Chinese population.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Analysis of silent information regulator 1 (SIRT1) gene polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in a prospective cohort study
    Wang, Yu
    Yan, Xiu-Ying
    Wu, Jing-Can
    Ji, Gui-Yi
    Wu, Shou-Quan
    Huang, Wei-Wei
    Chen, Guo
    Sandford, Andrew J.
    He, Jian-Qing
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (10) : 775 - 781
  • [42] The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies
    Zheng, Jing
    Guo, Mei-Hong
    Peng, He-Wei
    Cai, Xiao-Ling
    Wu, Yun-Li
    Peng, Xian-E
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [43] Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity
    Lee, Shih-Wei
    Chen, Pei-Tzu
    Liu, Chi-Wei
    Li, Yuan-Hsu
    Wu, Lawrence Shih-Hsin
    PHARMACOGENOMICS, 2024, 25 (5-6) : 241 - 247
  • [44] Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population
    Lu, Lihuan
    Tao, Bilin
    Wei, Haixu
    Chen, Hongbo
    He, Xiaomin
    Pan, Hongqiu
    Yang, Miaomiao
    Yi, Honggang
    Tang, Shaowen
    JOURNAL OF GENE MEDICINE, 2019, 21 (06)
  • [45] Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial
    Zhang, Simin
    Pan, Hongqiu
    Peng, Xianzhen
    Lu, Hui
    Fan, Hong
    Zheng, Xianzhi
    Xu, Guisheng
    Wang, Min
    Wang, Jianming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (02) : 409 - 416
  • [46] A nomogram model to predict the risk of drug-induced liver injury in patients receiving anti-tuberculosis treatment
    Ji, Songjun
    Lu, Bin
    Pan, Xinling
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [47] Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis
    Saito, Zenya
    Kaneko, Yugo
    Kinoshita, Akira
    Kurita, Yusuke
    Odashima, Kyuto
    Horikiri, Tsugumi
    Yoshii, Yutaka
    Seki, Aya
    Seki, Yoshitaka
    Takeda, Hiroshi
    Kuwano, Kazuyoshi
    BMC INFECTIOUS DISEASES, 2016, 16
  • [48] Is anti-tuberculosis drug-induced hepatotoxicity due to a change in pharmacokinetics caused by alterations in antioxidant gene expression and polymorphisms in the NFE2L2 gene?
    Ji, Guiyi
    Huang, Weiwei
    He, Jianqing
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (02) : 67 - 73
  • [49] An Investigation of the Risk Factors Associated With Anti-Tuberculosis Drug-Induced Liver Injury or Abnormal Liver Functioning in 757 Patients With Pulmonary Tuberculosis
    Zhong, Tao
    Fan, Yuzheng
    Dong, Xiao-Li
    Guo, Xujun
    Wong, Ka Hing
    Wong, Wing-tak
    He, Daihai
    Liu, Shengyuan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [50] Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han
    Chen, Guo
    Wu, Shou-Quan
    Feng, Mei
    Wang, Yu
    Wu, Jing-Can
    Ji, Gui-Yi
    Zhang, Miao-Miao
    Liu, Qian-Qian
    He, Jian-Qing
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2017, 30 (04) : 434 - 438